Latest EU patient information plan includes fresh drug safety measures
This article was originally published in SRA
Executive Summary
The latest draft of the European Commission's proposed legislation on patient information will allow pharmaceutical companies to provide information on their prescription drugs to the public, but only in a very circumscribed manner. It will also place an obligation on them to make certain information available, such as the product's labelling and pack leaflet.